<code id='A8B0A1BBAE'></code><style id='A8B0A1BBAE'></style>
    • <acronym id='A8B0A1BBAE'></acronym>
      <center id='A8B0A1BBAE'><center id='A8B0A1BBAE'><tfoot id='A8B0A1BBAE'></tfoot></center><abbr id='A8B0A1BBAE'><dir id='A8B0A1BBAE'><tfoot id='A8B0A1BBAE'></tfoot><noframes id='A8B0A1BBAE'>

    • <optgroup id='A8B0A1BBAE'><strike id='A8B0A1BBAE'><sup id='A8B0A1BBAE'></sup></strike><code id='A8B0A1BBAE'></code></optgroup>
        1. <b id='A8B0A1BBAE'><label id='A8B0A1BBAE'><select id='A8B0A1BBAE'><dt id='A8B0A1BBAE'><span id='A8B0A1BBAE'></span></dt></select></label></b><u id='A8B0A1BBAE'></u>
          <i id='A8B0A1BBAE'><strike id='A8B0A1BBAE'><tt id='A8B0A1BBAE'><pre id='A8B0A1BBAE'></pre></tt></strike></i>

          Home / comprehensive / leisure time

          leisure time


          leisure time

          author:comprehensive    Page View:457
          Alexis Borisy
          Venture capitalist Alexis Borisy Vanessa Leroy for STAT

          EQRx is done, sold for its cash.

          The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.

          advertisement

          The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In